BOYA BIO-PHARMACEU
300294 SZSE

300294
BOYA BIO-PHARMACEU SZSE
 
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E

300294 Stock Chart

Valuation
Enterprise Value/EBITDA, TTM
Enterprise Value, FQ
Market Cap — Basic
Number of Employees
Number of Shareholders
Price/Earnings, TTM
Price/Revenue, TTM
Price/Book Ratio, FY
Price/Sales Ratio, FY
Balance Sheet
Current Ratio, FQ
Debt to Equity, FQ
Net Debt, FQ
Quick Ratio, FQ
Total Assets, FQ
Total Debt, FQ
Operating Metrics
Return on Assets, TTM
Return on Equity, TTM
Return on Invested Capital, TTM
Revenue per Employee, TTM
Price History
Average Volume (10 day)
Beta - 1 Year
Price - 52 Week High
Price - 52 Week Low
Dividends
Dividends Paid, FY
Dividends per Share, FY
Expected Annual Dividends
Dividends Yield
Margins
Net Margin, TTM
Gross Margin, TTM
Operating Margin, TTM
Pretax Margin, TTM
Income Statement
Basic EPS, Net Income
Earnings per Share, Basic, TTM
EBITDA, TTM
Gross Profit, FY
Last Annual EPS
Last Annual Revenue, FY
Net Income, FY
Total Revenue, FY
Free Cash Flow, TTM

Profile

Sector: Health Technology
Industry: Medical Specialties
Boya Bio-pharmaceutical Group Co., Ltd. engages in the research, development, production, and sale of blood products. It operates through the following business segments: Blood Products, Diabetes Medication, and Biochemical drugs. The Blood Products segment includes products such as albumin, immunoglobulin, and blood clotting factors. The Diabetes Medication segment includes metformin hydrochloride tablets, enteric-coated tablets, and calcium hydroxybenzenesulfonate capsules. The Biochemical Drugs segment includes medication such as compound bone peptide injections, oxytocin injections, and heparin sodium injections. The company was founded on November 6, 1993 and is headquartered in Fuzhou, China.

News